Inhibrx Biosciences, Inc.盘中异动早盘大幅拉升5.09%报16.15美元

市场透视10-28

北京时间2024年10月28日22时22分，Inhibrx Biosciences, Inc.（INBX.us）股票出现异动，股价急速拉升5.09%。截至发稿，该股报16.15美元/股，成交量5087股，换手率0.04%，振幅2.78%。最近的财报数据显示，该股实现营业收入100000.00美元，净利润18.58亿美元，每股收益128.35美元，毛利-375000.00美元，市盈率0.13倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2478548421?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-28 22:22","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2478548421","market":"us","top_or_hot":-1,"title":"Inhibrx Biosciences, Inc.盘中异动 早盘大幅拉升5.09%报16.15美元","media":"市场透视","content":"<div>\n<p>北京时间2024年10月28日22时22分，Inhibrx Biosciences, Inc.（INBX.us）股票出现异动，股价急速拉升5.09%。截至发稿，该股报16.15美元/股，成交量5087股，换手率0.04%，振幅2.78%。最近的财报数据显示，该股实现营业收入100000.00美元，净利润18.58亿美元，每股收益128.35美元，毛利-375000.00美元，市盈率0.13倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222241a1f2692f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inhibrx Biosciences, Inc.盘中异动 早盘大幅拉升5.09%报16.15美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInhibrx Biosciences, Inc.盘中异动 早盘大幅拉升5.09%报16.15美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-28 22:22 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222241a1f2692f&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月28日22时22分，Inhibrx Biosciences, Inc.（INBX.us）股票出现异动，股价急速拉升5.09%。截至发稿，该股报16.15美元/股，成交量5087股，换手率0.04%，振幅2.78%。最近的财报数据显示，该股实现营业收入100000.00美元，净利润18.58亿美元，每股收益128.35美元，毛利-375000.00美元，市盈率0.13倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222241a1f2692f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INBX","symbol_name":"Inhibrx Biosciences","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222241a1f2692f&s=b","article_id":"2478548421","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222241a1f2692f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2478548421","pubTimestamp":1730125361,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月28日22时22分，Inhibrx Biosciences, Inc.股票出现异动，股价急速拉升5.09%。截至发稿，该股报16.15美元/股，成交量5087股，换手率0.04%，振幅2.78%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"INBX":"Inhibrx Biosciences","BK4139":"生物科技"},"translate_title":"Inhibrx Biosciences, Inc. surged 5.09% to $16.15 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INBX":1},"content_text":"北京时间2024年10月28日22时22分，Inhibrx Biosciences, Inc.（INBX.us）股票出现异动，股价急速拉升5.09%。截至发稿，该股报16.15美元/股，成交量5087股，换手率0.04%，振幅2.78%。最近的财报数据显示，该股实现营业收入100000.00美元，净利润18.58亿美元，每股收益128.35美元，毛利-375000.00美元，市盈率0.13倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Monte Rosa Therapeutics, Inc.、Eyepoint Pharmaceuticals, Inc.涨幅较大，Tc Biopharm (Holdings) Plc、Genprex, Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为626.51%、53.87%、52.33%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)、Monte Rosa Therapeutics, Inc.，振幅分别为87.13%、84.14%、46.83%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。其临床治疗候选药物包括INBRX-109和INBRX-106，这两种药物均采用多价形式，可以以靶向为中心的方式优化精确的价态，以调节专家认为是主要的激动剂功能。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2478548421"}

Inhibrx Biosciences, Inc.盘中异动 早盘大幅拉升5.09%报16.15美元

精彩评论

Inhibrx Biosciences, Inc.盘中异动早盘大幅拉升5.09%报16.15美元